Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mickaël Burgy"'
Autor:
Carinato Hélène, Ombline Conrad, Carole Pflumio, Christian Borel, Manon Voegelin, Alexandre Bernard, Philippe Schultz, Mihaela-Alina Onea, Alain Jung, Sophie Martin, Mickaël Burgy
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Immune checkpoint inhibitors of programmed cell death protein 1 (PD-1) represent a significant breakthrough in treating head and neck squamous cell carcinoma (HNSCC), with long-lasting responses and prolonged survival observed in
Externí odkaz:
https://doaj.org/article/08f90ea39b7d47d7af11c760d913a1cd
Autor:
Jana Mourtada, Christelle Lony, Anaïs Nicol, Justine De Azevedo, Cyril Bour, Christine Macabre, Patrick Roncarati, Sonia Ledrappier, Philippe Schultz, Christian Borel, Mickaël Burgy, Bohdan Wasylyk, Georg Mellitzer, Michaël Herfs, Christian Gaiddon, Alain C. Jung
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundDeconvoluting the heterogenous prognosis of Human Papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OSCC) is crucial for enhancing patient care, given its rapidly increasing incidence in western countries and the adverse s
Externí odkaz:
https://doaj.org/article/bf2a6ac09adb4bfcbe807400b5a4314a
Autor:
Ombline Conrad, Mickaël Burgy, Sophie Foppolo, Aude Jehl, Alicia Thiéry, Sébastien Guihard, Romain Vauchelles, Alain C. Jung, Jana Mourtada, Christine Macabre, Sonia Ledrappier, Marie-Pierre Chenard, Mihaela-Alina Onea, Aurélien Danic, Thomas Dourlhes, Claire Thibault, Philippe Schultz, Monique Dontenwill, Sophie Martin
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 11178 (2023)
Head and neck squamous cell carcinomas (HNSCCs) are heterogeneous tumors, well known for their frequent relapsing nature. To counter recurrence, biomarkers for early diagnosis, prognosis, or treatment response prediction are urgently needed. miRNAs c
Externí odkaz:
https://doaj.org/article/9853557f254d447ba7097c04c610f09e
Autor:
Aude Jehl, Ombline Conrad, Mickaël Burgy, Sophie Foppolo, Romain Vauchelles, Carole Ronzani, Nelly Etienne-Selloum, Marie-Pierre Chenard, Aurélien Danic, Thomas Dourlhes, Claire Thibault, Philippe Schultz, Monique Dontenwill, Sophie Martin
Publikováno v:
Cells, Vol 12, Iss 5, p 733 (2023)
(1) Background: Epiregulin (EREG) is a ligand of EGFR and ErB4 involved in the development and the progression of various cancers including head and neck squamous cell carcinoma (HNSCC). Its overexpression in HNSCC is correlated with short overall su
Externí odkaz:
https://doaj.org/article/3e9071dc52d54cf3b2ba7636d9de5a6d
Autor:
Hélène Carinato, Mickaël Burgy, Régine Ferry, Cathie Fischbach, Michal Kalish, Sébastien Guihard, Youssef Brahimi, Henri Flesch, Guy Bronner, Philippe Schultz, Véronique Frasie, Alicia Thiéry, Martin Demarchi, Thierry Petit, Alain C. Jung, Pierre Wagner, Pierre Coliat, Christian Borel
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveFor most patients suffering from recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC), chemotherapy is the main option after considering surgery and reirradiation. Cetuximab combined with a platinum-fluorouracil regi
Externí odkaz:
https://doaj.org/article/d90ef3bc072c436280ad7434dde5db47
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-5 (2019)
Abstract Background Oligodendroglioma is a rare type of primary brain tumor which, like other malignant gliomas, metastasizes very rarely even when in high-grade form. Case report A 36-year-old white man diagnosed 29 months previously as having 1p/19
Externí odkaz:
https://doaj.org/article/49e7b31b827b44989300b37905ab908d
Autor:
Mickaël Burgy, Aude Jehl, Ombline Conrad, Sophie Foppolo, Véronique Bruban, Nelly Etienne-Selloum, Alain C. Jung, Murielle Masson, Christine Macabre, Sonia Ledrappier, Hélène Burckel, Carole Mura, Georges Noël, Christian Borel, François Fasquelle, Mihaela-Alina Onea, Marie-Pierre Chenard, Alicia Thiéry, Monique Dontenwill, Sophie Martin
Publikováno v:
Cancers, Vol 13, Iss 12, p 3038 (2021)
The EGFR-targeting antibody cetuximab (CTX) combined with radiotherapy is the only targeted therapy that has been proven effective for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Recurrence arises in 50% of pat
Externí odkaz:
https://doaj.org/article/cf6ec7c6c2d54937afdc4489ee108c8f
Publikováno v:
Cancers, Vol 12, Iss 9, p 2691 (2020)
Head and neck squamous cell carcinoma (HNSCC) in the recurrent or metastatic (R/M) setting is a devastating disease with a poor prognosis. Until recently, the reference first line treatment was the EXTREME protocol, which yields a 10.1 months median
Externí odkaz:
https://doaj.org/article/b20f1901458c4c94b8af47d840ac2c54
Autor:
Martin, Ombline Conrad, Mickaël Burgy, Sophie Foppolo, Aude Jehl, Alicia Thiéry, Sébastien Guihard, Romain Vauchelles, Alain C. Jung, Jana Mourtada, Christine Macabre, Sonia Ledrappier, Marie-Pierre Chenard, Mihaela-Alina Onea, Aurélien Danic, Thomas Dourlhes, Claire Thibault, Philippe Schultz, Monique Dontenwill, Sophie
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 11178
Head and neck squamous cell carcinomas (HNSCCs) are heterogeneous tumors, well known for their frequent relapsing nature. To counter recurrence, biomarkers for early diagnosis, prognosis, or treatment response prediction are urgently needed. miRNAs c
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-5 (2019)
Journal of Medical Case Reports
Journal of Medical Case Reports
Background Oligodendroglioma is a rare type of primary brain tumor which, like other malignant gliomas, metastasizes very rarely even when in high-grade form. Case report A 36-year-old white man diagnosed 29 months previously as having 1p/19q codelet